Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, that it has installed additional Nuclear Magnetic Resonance (NMR) equipment which will double Lifespin’s annual laboratory testing capacity
Latest Press Releases
— Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Pharmaceutical industry.
Single Pass, Inc. CEO, Bill Colone, the initiation of the clinical evaluation for the Kronos Electrocautery device designed to improve the safety of co-axial biopsy procedures.
NaNotics LLC, a biopharmaceutical company developing NaNots™, novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood.
Fresenius Kabi, a global health care company that specializes in pharmaceuticals, medical technologies, and nutrition products for critical and chronic conditions.
Novogene at the forefront of cutting-edge next-generation sequencing (NGS) services, has officially Falcon II, a superpowered robot scientist for autonomously intelligent NGS delivery.
QOL Medical, LLC, a ground-breaking, rare disease pharmaceutical company, that the United States (U.S.) Food & Drug Administration (FDA) approved Sucraid®.
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), a significant expansion of its world-class facility in Tredegar, Wales, UK, designed to help keep pace with the market growth of powerful, targeted oncology therapies.
Advanced Instruments at the American Association for Clinical Chemistry trade show in Chicago the newest addition to its clinical line of freezing point osmometers, the OsmoPRO MAX Automated Osmometer.
Fresenius Kabi the immediate availability in the U.S. of Glycopyrrolate Injection, USP in 0.6 mg per 3 mL Simplist® ready-to-administer prefilled syringes.
As many Korean pharmaceutical manufacturers are currently attempting to develop new drugs for idiopathic pulmonary fibrosis, Daewoong Pharmaceutical's new medication.